Search
Close
Search
Advanced Search
Search Menu
AI Discovery Assistant

Extract

My tenure to date as Editor-in-Chief for Neuro-Oncology has been a privilege and a passion. I am immensely grateful for the generosity of the editorial board and their dedication and commitment to ensure that the needs of all stakeholders are addressed. I would like to thank Annie Huang who completed her term as Associate Editor this year and who was instrumental in highlighting and prioritizing pediatric neuro-oncology submissions. I also welcome Matt Dun who will handle basic and translational pediatric neuro-oncology submissions to complement Maryam Fouladi’s and Bill Weiss’s great contributions. To address the increase in manuscripts incorporating artificial intelligence and machine learning, Spyridion Bakas has also agreed to serve as an Associate Editor, and Quinn Ostrom will join Jill Barnholtz Sloan in handling epidemiology and biostatistical focused manuscripts. The expansion of the Associate Editors, commitment of the Editorial Board members, and the addition of the recently graduated Editorial Scholars from the class of 2023, all contribute to high-quality and efficient peer review. This is important since the numbers of submission to Neuro-Oncology continue to increase, with a 25% increase since 2023 and currently more than 100 submissions per month. I am extremely grateful to the Board, Managing Editor Elizabeth Martinson, and the team at Oxford University Press who work collectively to keep our target for the time for initial review of all manuscripts at 14 days and time for the first decision below 30 days.

Issue Section:
Letter to the Editor
You do not currently have access to this article.
Download all slides